ISP ACQUISITION COMPANY, INC.

Drug delivery systems in the form of oral capsules that provide controlled release of the active ingredients for a wide variety of therapeutic agents

House mark for a full line of pharmaceutical products, preparations, and substances

House mark for a full line of pharmaceutical products, preparations, and substances

Pharmaceuticals for the treatment of neurological and metabolic related diseases and disorders; pharmaceutical preparations and substances for the treatment of cognitive disorders

Class 005: Pharmaceuticals for the treatment of viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, drug addiction, substance abuse, and immune system related diseases and disorders; pharmaceuticals for the treatment of mosquito-borne illnesses; antibiotics; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, and obesity; pharmaceuticals for immunosuppression, namely, solid organ transplant; contraceptive preparations; pharmaceuticals for the prevention of opioid toxicity or overdosage, chemical or nerve agent toxicity, and radiation poisoning or sickness

Pharmaceuticals for the treatment of psychiatric related diseases and disorders

Pharmaceuticals for the treatment metabolic related diseases and disorders

Pharmaceuticals for the treatment of neurological diseases and disorders; pharmaceutical preparations and substances for the treatment of cognitive disorders | Research and development services in the field of dosage forms for extended release pharmaceuticals